Miroslava Katičić, Department of Gastroenterology, Merkur University Hospital, 10000 Zagreb, Croatia.
World J Gastroenterol. 2012 Aug 28;18(32):4300-7. doi: 10.3748/wjg.v18.i32.4300.
To study the epidemiologic indicators of uptake and characteristic colonoscopic findings in the Croatian National Colorectal Cancer Screening Program.
Colorectal cancer (CRC) was the second leading cause of cancer mortality in men (n = 1063, 49.77/100,000), as well as women (n = 803, 34.89/100,000) in Croatia in 2009. The Croatian National CRC Screening Program was established by the Ministry of Health and Social Welfare, and its implementation started in September, 2007. The coordinators were recruited in each county institute of public health with an obligation to provide fecal occult blood testing (FOBT) to the participants, followed by colonoscopy in all positive cases. The FOBT was performed by hypersensitive guaiac-based Hemognost card test (Biognost, Zagreb). The test and short questionnaire were delivered to the home addresses of all citizens aged 50-74 years consecutively during a 3-year period. Each participant was required to complete the questionnaire and send it together with the stool specimen on three test cards back to the institute for further analysis. About 4% FOBT positive cases are expected in normal risk populations. A descriptive analysis was performed.
A total of 1,056,694 individuals (born between 1933-1945 and 1952-1957) were invited to screening by the end of September 2011. In total, 210,239 (19.9%) persons returned the envelope with a completed questionnaire, and 181,102 of them returned it with a correctly placed stool specimen on FOBT cards. Until now, 12,477 (6.9%), FOBT-positive patients have been found, which is at the upper limit of the expected values in European Guidelines for Quality Assurance in CRC Screening and Diagnosis [European Union (EU) Guidelines]. Colonoscopy was performed in 8541 cases (uptake 66%). Screening has identified CRC in 472 patients (5.5% of colonoscopied, 3.8% of FOBT-positive, and 0.26% of all screened individuals). This is also in the expected range according to EU Guidelines. Polyps were found and removed in 3329 (39% of colonoscopied) patients. The largest number of polyps were found in the left half of the colon: 64% (19%, 37% and 8% in the rectum, sigma, and descendens, respectively). The other 36% were detected in the proximal part (17% in the transverse colon and 19% in ceco-ascending colon). Small polyps in the rectum (5-10 mm in diameter), sigmoid and descending colon were histologically found to be tubular adenomas in 60% of cases, with a low degree of dysplasia, and 40% were classified as hyperplastic. Polyps of this size in the transverse or ceco-ascending colon in almost 20% had a histologically villous component, but still had a low degree of dysplasia. Polyps sized 10-20 mm in diameter were in 43% cases tubulovillous, and among them, 32% had areas with a high degree of dysplasia, especially those polyps in the ceco-ascending or transverse part. The characteristics of the Croatian CRC Screening National Program in the first 3 years were as follows: relatively low percentage of returned FOBT, higher number of FOBT-positive persons but still in the range for population-based programs, and higher number of pathologic findings (polyps and cancers).
These results suggest a need for intervention strategies that include organizational changes and educational activities to improve awareness of CRC screening usefulness and increase participation rates.
研究克罗地亚国家结直肠癌筛查计划中采用率的流行病学指标和特征性结肠镜检查结果。
2009 年,结直肠癌(CRC)是克罗地亚男性(n=1063,49.77/100000)和女性(n=803,34.89/100000)的第二大癌症死亡原因。克罗地亚国家 CRC 筛查计划由卫生部和社会福利部设立,于 2007 年 9 月开始实施。协调员在每个县的公共卫生研究所招聘,有义务向参与者提供粪便潜血试验(FOBT),然后对所有阳性病例进行结肠镜检查。FOBT 通过超敏基于愈创木脂的 Hemognost 卡片试验(Biognost,萨格勒布)进行。该试验和简短问卷在 3 年内连续递送到所有 50-74 岁公民的家庭住址。要求每位参与者填写问卷,并将 3 张粪便标本的卡片寄回研究所进行进一步分析。在正常风险人群中,预计有 4%的 FOBT 阳性病例。进行了描述性分析。
截至 2011 年 9 月底,共有 1056694 人(1933-1945 年和 1952-1957 年出生)受邀参加筛查。共有 210239 人(19.9%)返回了带有完整问卷的信封,其中 181102 人将其与 FOBT 卡上正确放置的粪便标本一起返回。迄今为止,发现了 12477 名(6.9%)FOBT 阳性患者,这处于欧洲 CRC 筛查和诊断质量保证指南[欧盟(EU)指南]的预期值上限。对 8541 例(采用率 66%)患者进行了结肠镜检查。筛查发现 472 例 CRC(结肠镜检查的 5.5%,FOBT 阳性的 3.8%,所有筛查个体的 0.26%)。这也符合欧盟指南的预期范围。在 3329 例(结肠镜检查的 39%)患者中发现并切除了息肉。左半结肠发现的息肉数量最多:64%(直肠、乙状结肠和降结肠分别为 19%、37%和 8%)。其余 36%位于近端(横结肠 17%,升结肠和降结肠 19%)。直肠(直径 5-10 毫米)、乙状结肠和降结肠的小息肉在 60%的病例中组织学上发现为管状腺瘤,低度异型增生,40%被归类为增生性。在几乎 20%的横结肠或升结肠的这些大小的息肉中,组织学上有绒毛成分,但仍有低度异型增生。直径 10-20 毫米的息肉在 43%的病例中为管状绒毛状,其中 32%有高度异型增生区域,尤其是在升结肠或横结肠部分的息肉。克罗地亚 CRC 筛查国家计划前 3 年的特征如下:返回 FOBT 的百分比相对较低,FOBT 阳性人数较多,但仍在基于人群的计划范围内,病理发现(息肉和癌症)较多。
这些结果表明,需要采取干预策略,包括组织变革和教育活动,以提高对 CRC 筛查有用性的认识并提高参与率。